O. Kan
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- CRISPR and Genetic Engineering 4
- Retinal Development and Disorders 4
- RNA Interference and Gene Delivery 3
- PI3K/AKT/mTOR signaling in cancer 2
- Genetics 6
- Virus-based gene therapy research 6
- Co-authors
- Anthony D. Whetton (7 shared papers)Stephen A. Baldwin (3 shared papers)Sharifah Iqball (8 shared papers)C M Heyworth (3 shared papers)T. M. Dexter (3 shared papers)Susan M. Kingsman (3 shared papers)Simon Naylor (5 shared papers)K. Binley (3 shared papers)
- Journals
- Human Gene Therapy (2 papers)The Journal of Gene Medicine (2 papers)Growth Factors (2 papers)Gene Therapy (2 papers)Biochemical Society Transactions (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
O. Kan
19 papers receiving 740 citations
Peers
Comparison fields: 5 of 72
- Ophthalmology 95
- Biotechnology 69
- Cancer Research 116
- Immunology 162
- Genetics 202
Countries citing papers authored by O. Kan
This map shows the geographic impact of O. Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Kan more than expected).
Fields of papers citing papers by O. Kan
This network shows the impact of papers produced by O. Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Kan. The network helps show where O. Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 164 | |
| 2 | 1990 | 109 | |
| 3 | 1994 | 104 | |
| 4 | 2005 | 74 | |
| 5 | 2005 | 72 | |
| 6 | 2006 | 47 | |
| 7 | 2001 | 40 | |
| 8 | 2009 | 37 | |
| 9 | 2002 | 27 | |
| 10 | 1991 | 20 | |
| 11 | 2007 | 19 | |
| 12 | 1991 | 13 | |
| 13 | 1994 | 12 | |
| 14 | Exploiting the hypoxia response. | 2003 | 10 |
| 15 | 2000 | 5 | |
| 16 | 2008 | 4 | |
| 17 | 1994 | 4 | |
| 18 | 1992 | 3 | |
| 19 | Evaluation of EIAV Based Lentiviral Vectors Following Ocular Delivery in the Nonhuman Primate Model: Development of RetinoStat® | 2008 | 1 |
| 20 | 1999 | 1 |
About O. Kan
O. Kan is a scholar working on Molecular Biology, Genetics, Ophthalmology, Immunology and Genetics, having authored 20 papers that have together received 766 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (4 papers), Retinal Diseases and Treatments (4 papers), Retinal Development and Disorders (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Ophthalmology (95 citations), Biotechnology (69 citations), Cancer Research (116 citations), Immunology (162 citations) and Genetics (202 citations). O. Kan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony D. Whetton, Stephen A. Baldwin, Sharifah Iqball, C M Heyworth, T. M. Dexter, Susan M. Kingsman, Simon Naylor, K. Binley, Stuart Naylor and Adrian L. Harris. Their work appears in journals such as Human Gene Therapy, The Journal of Gene Medicine, Growth Factors, Gene Therapy and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.